BiochemistrybioRxivPreprint
AB668, a novel highly selective protein kinase CK2 inhibitor with a distinct anti-tumor mechanism as compared to CX-4945 and SGC-CK2-1
A. Bancet, R. Frem, F. Jeanneret…·I. Krimm
The paper introduces AB668, a selective CK2 inhibitor with a distinct anti-tumor mechanism compared to CX-4945 and SGC-CK2-1, showing apoptotic effects and pathway stimulation in cancer cells.
DOI 10.1101/2022.12.16.520736